Biosimilar Candidate B
Oncology Supportive Care
Phase I / Phase IIActive
Key Facts
Indication
Oncology Supportive Care
Phase
Phase I / Phase II
Status
Active
About China Resources Pharmaceutical Group
CR Pharma's mission is to serve as a foundational pillar of China's national healthcare system through its integrated pharmaceutical platform. Its key achievements include establishing one of the country's largest distribution networks, a significant manufacturing base, and an extensive retail pharmacy chain under the CRCare brand. The company's strategy is centered on vertical integration, leveraging its state-backed position to consolidate market share, control supply chains, and commercialize products from its R&D pipeline across key therapeutic areas. This approach aims to secure sustainable growth amid government-led volume-based procurement and an aging population.
View full company profileTherapeutic Areas
Other Oncology Supportive Care Drugs
| Drug | Company | Phase |
|---|---|---|
| IL-2 Efficacy Program | Aelan Cell Technologies | Research |